Article
Author(s):
Fort Lauderdale, FL-New innovative approaches for treating dry eye have been emerging that researchers hope will alleviate symptoms for the enormous number of patients affected by this disease.
Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Recent changes to cornea: Preferred Practice Patterns
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Innovation and the clinician-scientist
FDA accepts NDA from Aldeyra Therapeutics for reproxalap for dry eye